Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema

Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema

Abstract Background and objectives Several treatments for long-term prophylaxis (LTP) of hereditary angioedema (HAE) are in clinical use, such as garadacimab, lanadelumab, subcutaneous C1 esterase inhibitor (C1INH), and berotralstat. In the absence of head-to-head comparative evidence, indirect comp...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarah Walsh, Meaghan Bartlett, Elizabeth M. Salvo-Halloran, John Sears, Yinglei Li, Maebh Kelly, Simona Gavata-Steiger, Chiara Nenci, Iris Jacobs, Ingo Pragst, Neelanjana Ray, Imtiaz A. Samjoo
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-05-01
Series:Drugs in R&D
Online Access:https://doi.org/10.1007/s40268-025-00511-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40268-025-00511-y

Similar Items